ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 944

$697K Total Retail Price of All Prescriptions

Rank: 73 out of 944

475 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 9,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 389 303 1 2
FUROSEMIDE 383 329 2 6
LISINOPRIL 314 289 3 3
PRAVASTATIN SODIUM 278 271 4 17
POTASSIUM CHLORIDE 257 209 5 15
SIMVASTATIN 255 239 6 1
HYDROCODONE-ACETAMINOPHEN 241 215 S3 7 10
WARFARIN SODIUM 213 210 8 7
AMLODIPINE BESYLATE 207 186 9 5
OMEPRAZOLE 200 178 10 4
CITALOPRAM HBR 190 176 11 19
DONEPEZIL HCL 161 150 12 24
ATORVASTATIN CALCIUM 151 143 13 13
METOPROLOL TARTRATE 151 144 13 8
CLOPIDOGREL 147 140 15 36
RANITIDINE HCL 146 127 16 42
LOSARTAN POTASSIUM 143 129 17 16
TRAZODONE HCL 141 120 18 45
CARVEDILOL 130 123 19 30
NAMENDA 128 128 20 37
SERTRALINE HCL 124 90 21 23
ALLOPURINOL 124 115 21 22
ATENOLOL 119 119 23 11
METFORMIN HCL 107 87 24 12
PANTOPRAZOLE SODIUM 106 99 25 34
PLAVIX 105 104 26 55
FENOFIBRATE 102 93 27 58
VENLAFAXINE HCL ER 101 76 28 84
MELOXICAM 98 90 29 68
HYDROCHLOROTHIAZIDE 96 94 30 9
DIOVAN 96 79 30 38
METOPROLOL SUCCINATE 90 86 32 14
TAMSULOSIN HCL 88 82 33 27
AZITHROMYCIN 87 72 34 70
RAMIPRIL 86 79 35 144
ROPINIROLE HCL 85 77 36 96
GABAPENTIN 79 67 37 18
FINASTERIDE 75 68 38 83
MIRTAZAPINE 74 73 39 35
TRAMADOL HCL 73 66 40 21
SYNTHROID 72 72 41 82
ALENDRONATE SODIUM 70 70 42 20
PREDNISONE 70 59 42 32
SPIRONOLACTONE 69 51 44 44
DIGOXIN 68 63 45 39
LEVOFLOXACIN 67 59 46 117
DOXAZOSIN MESYLATE 64 64 47 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 61 48 141
ZOLPIDEM TARTRATE 63 35 48 25
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 59 48 155
CLOTRIMAZOLE-BETAMETHASONE 59 43 51 179
CLONIDINE HCL 59 59 51 67
PAROXETINE HCL 58 55 53 64
CYMBALTA 57 39 54 75
JANUVIA 55 50 55 81
LOVASTATIN 55 48 55 26
GLIPIZIDE 54 50 57 51
FLUTICASONE PROPIONATE 51 47 58 40
AVODART 51 51 58 226
ADVAIR DISKUS 51 38 58 31
GLIPIZIDE ER 50 45 61 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.